Clinical trials
Phase 1 Waldenstrom Macroglobulinemia trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| NCIC Clinical Trials Group | 2 |
| National Cancer Institute (NCI) | 2 |
| AbbVie | 1 |
| Eli Lilly and Company | 1 |
| Janssen Research & Development, LLC | 1 |
| Karyopharm Therapeutics Inc | 1 |
| London Health Sciences Centre | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Waldenstrom Macroglobulinemia | 9 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 8 |
| Lymphoma, B-Cell, Marginal Zone | 8 |
| Lymphoma, Follicular | 8 |
| Lymphoma, Mantle-Cell | 8 |
| Lymphoma, Large B-Cell, Diffuse | 6 |
| Lymphoma, Non-Hodgkin | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Burkitt Lymphoma | 5 |
| Lymphoma, Extranodal NK-T-Cell | 4 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.